Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gerber

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 30, 2004
Has a new hazard been added to failed sterilisations?Paul Gerber
The Medical Journal of Australia|May 6, 2009
Usefulness of Austroads' fitness-to-drive guidelines: lessons from the Gillett caseRoy G Beran, Paul Gerber, John A Devereux
Journal of Medicinal Chemistry|June 10, 2005
Validation and use of the MM-PBSA approach for drug discoveryBernd Kuhn, Paul Gerber, Tanja Schulz-Gasch, et al.
Bioconjugate Chemistry|May 19, 2005
Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2Christophe Dhalluin, Alfred Ross, Walter Huber, et al.
Journal of Medicinal Chemistry|May 30, 2003
Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screeningPierre C Wyss, Paul Gerber, Peter G Hartman, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 30, 2004
Has a new hazard been added to failed sterilisations?Paul Gerber
The Medical Journal of Australia|May 6, 2009
Usefulness of Austroads' fitness-to-drive guidelines: lessons from the Gillett caseRoy G Beran, Paul Gerber, John A Devereux
Journal of Medicinal Chemistry|June 10, 2005
Validation and use of the MM-PBSA approach for drug discoveryBernd Kuhn, Paul Gerber, Tanja Schulz-Gasch, et al.
Bioconjugate Chemistry|May 19, 2005
Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2Christophe Dhalluin, Alfred Ross, Walter Huber, et al.
Journal of Medicinal Chemistry|May 30, 2003
Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screeningPierre C Wyss, Paul Gerber, Peter G Hartman, et al.
Pageof 2